Literature DB >> 23008005

[Psoriasis in children and adolescents. A nationwide physician survey on the healthcare situation in Germany].

D Matusiewicz1, A Körber, D Schadendorf, J Wasem, A Neumann.   

Abstract

BACKGROUND: The aim of the present scientific study is the description of the current healthcare situation for children and adolescents with psoriasis in Germany.
METHODS: Data on psoriasis in children and adolescents (≤ 18) was obtained from randomly selected dermatologists and pediatricians throughout Germany. The participating doctors could include 1-3 patients from the year 2009 into the study.
RESULTS: The response rate to the survey was 9.7% for dermatologists and 1.9% for pediatricians. The study shows that psoriatic children and adolescents (n = 244) are treated primarily by dermatologists. With regard to the therapy approaches, 79.9% of the children and adolescents were treated with topical agents, 7.5% with physical modalities and 5.0% with systemic agents.
CONCLUSION: Psoriasis in childhood and adolescence is treated predominantly by dermatologists. Most of the patients were treated with topical corticosteroids. Childhood psoriasis is still a therapeutic challenge and further studies about the healthcare situation are necessary.

Entities:  

Mesh:

Year:  2012        PMID: 23008005     DOI: 10.1007/s00105-012-2431-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  9 in total

1.  Family history of psoriasis and age at disease onset in Italian patients with psoriasis.

Authors:  E Altobelli; R Petrocelli; C Marziliano; M C Fargnoli; M Maccarone; S Chimenti; K Peris
Journal:  Br J Dermatol       Date:  2007-06       Impact factor: 9.302

2.  Salient features and HLA markers of childhood psoriasis in Kuwait.

Authors:  A Nanda; A S Al-Fouzan; M El-Kashlan; N Al-Sweih; I Al-Muzairai
Journal:  Clin Exp Dermatol       Date:  2000-03       Impact factor: 3.470

3.  [Epidemiology of psoriasis in Germany--analysis of secondary health insurance data].

Authors:  I Schäfer; S J Rustenbach; M Radtke; J Augustin; G Glaeske; M Augustin
Journal:  Gesundheitswesen       Date:  2010-06-11

4.  Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial.

Authors:  Richard G Langley; Amy S Paller; Adelaide A Hebert; Kara Creamer; Haoling H Weng; Angelika Jahreis; Denise Globe; Vaishali Patel; Seth J Orlow
Journal:  J Am Acad Dermatol       Date:  2010-07-08       Impact factor: 11.527

5.  The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients.

Authors:  Nihal Kundakci; Umit Türsen; Muhammed O A Babiker; Erbak Gürgey
Journal:  Int J Dermatol       Date:  2002-04       Impact factor: 2.736

6.  A comparative study of pediatric onset psoriasis with adult onset psoriasis.

Authors:  S P Raychaudhuri; J Gross
Journal:  Pediatr Dermatol       Date:  2000 May-Jun       Impact factor: 1.588

7.  Long-term etanercept in pediatric patients with plaque psoriasis.

Authors:  Amy S Paller; Elaine C Siegfried; Lawrence F Eichenfield; David Pariser; Richard G Langley; Kara Creamer; Greg Kricorian
Journal:  J Am Acad Dermatol       Date:  2010-06-03       Impact factor: 11.527

Review 8.  Adult skin disease in the pediatric patient.

Authors:  R Howard; A Tsuchiya
Journal:  Dermatol Clin       Date:  1998-07       Impact factor: 3.478

9.  Epidemiology and comorbidity of psoriasis in children.

Authors:  M Augustin; G Glaeske; M A Radtke; E Christophers; K Reich; I Schäfer
Journal:  Br J Dermatol       Date:  2009-11-18       Impact factor: 9.302

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.